Year 4 (2019) Customer Satisfaction Survey for the CDC Antibiotic Resistance (AR) Isolate Bank
Form Approved
OMB Control No.: 0920-1071
Exp. Date: 2/28/2021
REQUEST TO CUSTOMER—FIRST WAVE:
FROM: [email protected]
TO: POCs from order list
SUBJECT: 10-min survey about AR Isolate Bank
Dear AR Isolate Bank customer,
The CDC & FDA Antibiotic Resistance Isolate Bank (AR Isolate Bank) was launched in July 2015 and, as we hit our four-year mark, we would like your feedback on how this resource has provided value to your organization and how it can be improved. Your feedback will help us target areas for improvement in our isolate collection and overall processes to ensure efficacy and value in the fight against antibiotic resistance.
Take the 10-minute survey here: [LINK]
The survey will close [DATE].
Based on your responses and with your permission, we may contact you to develop success stories that will be published on our website and in other CDC and FDA materials.
On behalf of CDC and FDA, we appreciate your participation in this survey.
Best,
Michael Craig, MPP
Senior Advisor for Antibiotic Resistance, Antibiotic Resistance Coordination and Strategy Unit
Centers for Disease Control and Prevention
Ribhi
M. Shawar, Ph.D, D(ABMM)
Branch Chief, General Bacteriology and
Antimicrobial Susceptibility Branch
CDRH/ OHT7/Division of
Microbiology Devices
Food
and Drug Administration
[email protected]
REQUEST TO CUSTOMER—SECOND WAVE:
FROM: [email protected]
TO: POCs from order list
SUBJECT: How is the AR Isolate Bank doing?
Dear AR Isolate Bank customer,
This is a reminder that the CDC & FDA Antibiotic Resistance Isolate Bank satisfaction survey will close [DATE].
Public
reporting burden of this collection of information is estimated to
average 10 minutes per response, including the time for reviewing
instructions, searching existing data sources, gathering and
maintaining the data needed, and completing and reviewing the
collection of information. An agency may not conduct or sponsor, and
a person is not required to respond to a collection of information
unless it displays a currently valid OMB Control Number. Send
comments regarding this burden estimate or any other aspect of this
collection of information, including suggestions for reducing this
burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE,
MS D-74, Atlanta, Georgia 30333; ATTN: PRA 0920-1071
Please take 10 minutes to complete the survey and provide feedback on how the AR Isolate Bank has provided value to your organization and how it can be improved.
Take the survey now: [LINK]
Based on your responses and with your permission, we may contact you to develop success stories that will be published on our website and in other CDC and FDA materials.
On behalf of CDC & FDA, we appreciate your participation in this survey. Your feedback will help us improve our repository to ensure efficacy and value in the fight against antibiotic resistance.
Best,
Michael Craig, MPP
Senior Advisor for Antibiotic Resistance, Antibiotic Resistance Coordination and Strategy Unit
Centers for Disease Control and Prevention
Ribhi
M. Shawar, Ph.D, D(ABMM)
Branch Chief, General Bacteriology and
Antimicrobial Susceptibility Branch
CDRH/OHT7/Division of
Microbiology Devices
Food
and Drug Administration
[email protected]
SURVEY HOSTED ON:
SurveyMonkey.com
INTRODUCTION:
Thank
you for providing feedback on the CDC & FDA Antibiotic Resistance
Isolate Bank.
The purpose of the survey is to capture how
the AR Isolate Bank has provided value to customers and how it can be
improved.
The information gathered from this survey will
inform next steps of AR Bank implementation and will not
be published.
PROPOSED QUESTIONS:
Have you ordered from the AR Isolate Bank within the last year (August 2018 – August 2019)? If no, why not?
Yes
No [open-ended]
Would you order from the AR Isolate Bank again? If no, why not?
Yes
No [open-ended]
Would you recommend the AR Isolate Bank to colleagues? If no, why not.
Yes
No [open-ended]
Which option below best describes your organization? [can select only one]
Academic (non-clinical)
Clinical laboratory (e.g., academic medical center, VA hospital, private hospital, public hospital, private laboratory, or reference laboratory)
Diagnostic manufacturer
Pharmaceutical manufacturer
U.S. Federal agency
Public health laboratory (city, county, or state)
Other (please describe)
How did you first hear about the AR Isolate Bank? [can select only one]
CDC website
FDA website
FDA request or suggestion to support a regulatory submission
Colleague
CLSI webinar
Publication
Scientific Conference/Meeting [open-ended]
Other: [open-ended]
What AR Isolate Bank panels have you/your organization ordered? Check all that apply.
How often have you/your organization ordered panels from the AR Isolate Bank? [can only select one]
1 occasion
2-5 occasions
6-9 occasions
10 occasions or more
How has your organization used the panels from the AR Isolate Bank? Check all that apply.
To develop (research, challenge, accelerate) a diagnostic device, test, or assay
To develop (research, challenge, accelerate) an antimicrobial or alternative therapy
To satisfy a specific request from FDA and/or support a premarket application
To validate a diagnostic test or element for implementation in my laboratory
To conduct basic/academic research
Other: [open-ended]
Based on your answer to Question #6, please provide more detail about how you have used the panels from the AR Isolate Bank. Please do not provide proprietary information. General descriptions for how the isolates helped improve process, increase product accuracy, meet organization priorities, add value, or support other AR strategies are appreciated. If you have not yet used the isolates, please explain how you intend to use them in the future. [open-ended]
Please take a moment to think about the AR Isolate Bank panels you received. Rate satisfaction with the following during your experience. [Likert scale: Very dissatisfied, Dissatisfied, Neither Dissatisfied nor Satisfied, Satisfied, Very satisfied, Not applicable]
Diversity of panels
Diversity of isolates available
Data available for isolates/panels
Descriptions of panel organisms
Viability of organisms
Confirmatory testing in your lab corresponded to isolate description
AR Isolate Bank staff assistance with troubleshooting problems with panels or isolates
Please comment on ratings given above about satisfaction with panels. [open-ended]
CDC and FDA are working together to expand the AR Isolate Bank collection. What additional features, isolates, panels, information would be valuable to you/your organization in the future? How can the current collection be improved? [open-ended]
If you have ordered isolates from other isolate repositories or organizations, what aspects of those services would you like to see implemented in the AR Isolate Bank (e.g. turnaround time, information provided with isolates, order/shipping process, etc.)? [open-ended]
Please take a moment to think about the AR Isolate Bank ordering process. Rate satisfaction with the following during your experience. [Likert scale: Very dissatisfied, Dissatisfied, Neutral, Satisfied, Very satisfied, Not applicable]
Ease of navigation through the AR Isolate Bank website
Ease of ordering
Responsiveness of AR Isolate Bank staff, if contacted
Duration of entire process (from initial order to delivery)
Please comment on ratings given above about satisfaction with the AR Isolate Bank ordering process. [open-ended]
Rate your satisfaction with the following AR Isolate Bank website features. [Likert scale: Very dissatisfied, Dissatisfied, Neither Dissatisfied nor Satisfied, Satisfied, Very satisfied, Not applicable]
AR Isolate Bank search feature
Characterization data provided with isolates
Downloadable materials
Ability to create a customer profile
Ordering instructions provided on the website
Order notifications and tracking
Other: [open-ended]
Please take a moment to think about the required documentation for isolate procurement. Have you encountered any difficulties understanding the instructions provided with each form or providing the information required? If yes, please describe.
Yes [open-ended]
No
Is there anything else you would like to tell us about your experiences using the AR Isolate Bank or the website? If yes, please list.
Yes [open-ended]
No
Has any of the work you have done using isolates from the AR Isolate Bank contributed to a scientific publication, public presentation, or regulatory submission? If yes, please list (e.g., citations, patent numbers, FDA approvals, etc.).
Yes [open-ended]
No
Can we contact you for additional information? To further develop the AR Isolate Bank collection, improve customer experience, and share success stories, we would like to contact some customers for more information about their experience. We will NOT publish responses provided in this survey or confidential, proprietary information. [can select only one]
If yes, please provide your name and email address. [open-ended]
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| File Modified | 0000-00-00 |
| File Created | 0000-00-00 |